Eleusis Email Format
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Eleusis is a clinical-stage biotechnology company focused on realizing the therapeutic potential of psychedelic medicines through research and development and a care-delivery framework. Founded in 2013 and based in London, England, it combines discovery and development capabilities with Andala’s care-delivery platform to address unmet needs in psychiatry and beyond. The company targets psychiatric disorders and related areas by advancing compounds from discovery toward care design. In October 2022, Eleusis was acquired by Beckley Psytech.